[1]
Yokom, D.W., Stewart, J., Alimohamed, N.S., Winquist, E., Barry, S., Hubay, S., Lattouf, J.-B., Leonard, H., Girolametto, C., Saad, F. and Sridhar, S.S. 2018. Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel. Canadian Urological Association Journal. 12, 8 (Mar. 2018). DOI:https://doi.org/10.5489/cuaj.5108.